Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

Entity

pseudohypoxia early-warning test

product1 mentionslast seen Oct 19, 2026

Test designed to identify patients at elevated risk for chronic diseases including diabetes, cancer, and cardiovascular disease.

Relationships 3

pseudohypoxia early-warning test

Relationship

SOD Sciences, Inc.developspseudohypoxia early-warning test

94% confidence1 supporting mentions

Either name opens that entity’s relationships.

Sources 1

filingSEC EDGAROct 19, 2026Vivos Therapeutics, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 2.01: Completion of Acquisition or Disposition of Assets; Item 3.02: Unregistered Sales of Equity Securities; Item 3.03: Material Modifications to Rights of Security Holders; Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Item 7.01: Regulation FD Disclosure; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
SOD Sciences, Inc. is a precision-health company and the developer of the ReBalU Protocol, which combines genetic and biomarker testing with a nutrition-based program and follow-up testing. SOD is also developing applications of its platform related to pseudohypoxia, including the pseudohypoxia early-warning test.